🎯Oncology (General)
Cancer-focused biotechs developing novel therapies including immunotherapies, targeted therapies, and combination treatments.
Market Cap$428.7B
1D+0.29%
Companies950
Public Cos165
SECTOR MARKET CAP
$428.7B+14913.5%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $153.7B | GILD |
| 2 |  | United States | $35.1B | RVMD |
| 3 |  | United States | $28.2B | ONC |
| 4 |  | United States | $17.0B | GH |
| 5 |  | China | $16.7B | 1801.HK |
| 6 |  | Denmark | $15.5B | GMAB |
| 7 |  | France | $14.7B | IPN.PA |
| 8 |  | China | $13.9B | 688506.SS |
| 9 |  | United States | $13.0B | EXEL |
| 10 |  | United Kingdom | $10.9B | SMMT |
| 11 |  | United States | $9.7B | NUVL |
| 12 |  | Japan | $8.2B | 4151.T |
| 13 |  | China | $8.2B | 002653.SZ |
| 14 |  | United States | $6.8B | LNTH |
| 15 |  | United States | $5.7B | CGON |
| 16 |  | United States | $5.1B | CAI |
| 17 |  | United States | $4.3B | VCYT |
| 18 |  | United States | $3.3B | ELVN |
| 19 |  | Finland | $2.4B | ORNAV.HE |
| 20 |  | United States | $2.0B | NUVB |